Xcelerating the Business of Global Healthcare
In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, […]
Xcelerate, Inc. Issues Shareholder Update
Mauldin, SC, Jan. 12, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC PINK: XCRT) Mike O’Shea, CEO, today released a shareholder update. 2021 has proven to be a formative year for Xcelerate during which we achieved reporting status with OTC Markets, began trading under our current symbol, introduced our corporate website, completed audits of consolidated financial statements […]
Xcelerate Acquires Controlling Interest in AfiyaSasa Africa
MAULDIN, S.C., Jan. 3, 2022 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: “XCRT”) today announced it has signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC, (“ASA”) a start-up medical technology and virtual health company that the Company believes is uniquely positioned to help patients in developing countries […]
Xcelerate, Inc. Signs Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC
MAULDIN, S.C., Aug. 26, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: “XCRT”) today announced that it has signed a Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC of Greenville, SC defining the terms under which Xcelerate, Inc. will acquire 100% of the membership interests in HS Pharmaceuticals, LLC as well as a 51% […]
Xcelerate Completes Audit of Consolidated Annual Financial Statements
MAULDIN, S.C., July 29, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC Pink Sheets: “XCRT”) today announced the completion of the audit of its Consolidated Annual Financial Statements for the fiscal years ending December 31, 2019, and December 31,2020. As previously announced, an independent auditor and PCOAB registered accounting firm, BF Borgers CPA PC, completed the […]
Xcelerate, Inc. Retains Accounting Firm For Audit
MAULDIN, S.C., June 22, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC Pink Sheets: “XCRT”) today announced it has retained BF Borgers CPA PC as the company’s independent accountant to audit its financial statements for years ending December 31, 2019 and 2020. The retention of the auditing firm is another step in the company’s plan to […]
Xcelerate, Inc. Announces Investment Banking Agreements for Consulting Services and Acquisition Financing
MAULDIN, S.C., June 10, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC: XCRT) announced today it has signed two investment banking agreements with a leading New York-based investment banking firm to assist in sourcing capital. (The investment banking firm was founded in the late 1980’s, is one of the oldest in the United States, a full-service […]
Dr. Barry Marshall Shares Xcelerate’s Mission In Advancing Medical Technology On ticker NEWS’ Globally-Streamed Broadcast
MAULDIN, S.C., May 13, 2021 /PRNewswire/ — Xcelerate, Inc’s (OTC: “XCRT”) Nobel Prize winner Dr. Barry Marshall, AC. FRACP, FAA,FRS,MBBS-UWA, who sits on the Advisory Board of Xcelerate, Inc. shared the Company’s mission of advancing medical technology in live appearance on Australia’s ticker NEWS’ globally streamed broadcast. In an in-depth interview, Dr. Marshall spoke […]
Xcelerate, Inc. Signs Letter of Intent to Explore Business Relationship with HS Pharmaceuticals
MAULDIN, S.C., May 6, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: XCRT) today announced it has signed a non-binding letter of intent to pursue a business combination with HS Pharmaceuticals, LLC of Greenville, SC. Over the past 14 years HS Pharmaceuticals has developed a platform of novel technologies centered around their patented and […]
Xcelerate Inc. Announces Removal of “Yield” Sign on OTC Markets Stock Quotes
MAULDIN, S.C., May 3, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: “XCERT), a rapidly emerging leader in assembling and developing early-stage medical technology, today announced it has taken all action necessary to remove the “Yield” sign from its stock symbol page provided by OTC Markets. The Company intends to continue its commitment to […]